• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.60% Nasdaq Down0.65%

    Insulet Corporation (PODD)

    -NasdaqGS
    29.64 Down 3.30(10.02%) 1:58PM EDT - Nasdaq Real Time Price
    ProfileGet Profile for:
    Insulet Corporation
    600 Technology Park Drive
    Suite 200
    Billerica, MA 01821
    United States - Map
    Phone: 978-600-7000
    Fax: 978-600-0120
    Website: http://www.insulet.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Instruments & Supplies
    Full Time Employees:N/A

    Business Summary 

    Insulet Corporation, a medical device company, develops, manufactures, and sells insulin infusion systems for people with insulin-dependent diabetes in the United States. The company offers OmniPod Insulin Management System (OmniPod System), which consists of the OmniPod, an easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes; and personal diabetes manager, a handheld wireless device. It also sells blood glucose testing supplies, insulin pumps, pump supplies, pharmaceuticals, and other products for the management and treatment of diabetes. The company sells and markets its OmniPod System through a combination of direct sales representatives and independent distributors. Insulet Corporation was founded in 2000 and is headquartered in Billerica, Massachusetts.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Insulet Corporation

    Corporate Governance 
    Insulet Corporation’s ISS Governance QuickScore as of May 1, 2016 is 8. The pillar scores are Audit: 2; Board: 2; Shareholder Rights: 10; Compensation: 4.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Patrick J. Sullivan , 64
    Chief Exec. Officer, Pres and Director
    1.50M0.00
    Mr. Michael L. Levitz , 42
    Chief Financial Officer and Sr. VP
    712.00K0.00
    Mr. Daniel J. Levangie B.S., 65
    Exec. VP and Pres of Insulet Drug Delivery
    816.00K0.00
    Ms. Shacey Petrovic , 42
    Exec. VP and Pres of Diabetes Products
    861.00K0.00
    Mr. Michael Spears , 51
    Sr. VP of Quality, Regulatory and Clinical Affairs
    543.00K0.00
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders